Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China
· Delayed Price · Currency is CNY 35.92
+1.59 (4.63%)
Apr 29, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Revenue
Hangzhou Biotest Biotech had revenue of 89.38M CNY in the quarter ending March 31, 2026, with 1.70% growth. This brings the company's revenue in the last twelve months to 449.50M, down -12.15% year-over-year. In the year 2025, Hangzhou Biotest Biotech had annual revenue of 448.01M, down -19.91%.
Revenue (ttm)
449.50M
Revenue Growth
-12.15%
P/S Ratio
11.69
Revenue / Employee
745.44K
Employees
622
Market Cap
5.26B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Bioperfectus Technologies | 339.05M |
| Beijing Scitop Bio-tech | 373.31M |
| ChemPartner PharmaTech | 1.07B |
| Assure Tech (Hangzhou) | 453.58M |
| Wuhan Hvsen Biotechnology | 1.74B |
| Beijing Bohui Innovation Biotechnology Group | 812.78M |
| Kexing Biopharm | 1.53B |
| PharmaResources (Shanghai) | 688.35M |